Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Dolasetron (compound)
Most Correlated Studies
- Drug target sets for approved compounds
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Most Relevant Literature
- Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From th…
- Perioperative doses of ondansetron or dolasetron do not lengthen the QT interval.
- Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and gr…
- Optimization of sample pretreatment methods for simultaneous determination of dolasetron and hydrodo…
- Inducing Cytotoxicity in Colon Cancer Cells and Suppressing Cancer Stem Cells by Dolasetron and Keto…
Most Relevant Clinical Trials
- Efficacy of Dolasetron in Patients With Fibromyalgia
- The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglit…
- Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting i…
- Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Canc…
- Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemo…
